These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650 [TBL] [Abstract][Full Text] [Related]
5. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach. Shanmugam V; Muthukrishnan S J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551 [TBL] [Abstract][Full Text] [Related]
6. Direct NMR Probing of Hydration Shells of Protein Ligand Interfaces and Its Application to Drug Design. Geist L; Mayer M; Cockcroft XL; Wolkerstorfer B; Kessler D; Engelhardt H; McConnell DB; Konrat R J Med Chem; 2017 Nov; 60(21):8708-8715. PubMed ID: 28910100 [TBL] [Abstract][Full Text] [Related]
7. PI by NMR: Probing CH-π Interactions in Protein-Ligand Complexes by NMR Spectroscopy. Platzer G; Mayer M; Beier A; Brüschweiler S; Fuchs JE; Engelhardt H; Geist L; Bader G; Schörghuber J; Lichtenecker R; Wolkerstorfer B; Kessler D; McConnell DB; Konrat R Angew Chem Int Ed Engl; 2020 Aug; 59(35):14861-14868. PubMed ID: 32421895 [TBL] [Abstract][Full Text] [Related]
8. In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1. Tumdam R; Kumar A; Subbarao N; Balaji BS SAR QSAR Environ Res; 2018 Dec; 29(12):975-996. PubMed ID: 30411639 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of a Höfurthner T; Toscano G; Kontaxis G; Beier A; Mayer M; Geist L; McConnell DB; Weinstabl H; Lichtenecker R; Konrat R J Biomol NMR; 2024 Mar; 78(1):1-8. PubMed ID: 37816933 [TBL] [Abstract][Full Text] [Related]
10. Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules. Urick AK; Hawk LM; Cassel MK; Mishra NK; Liu S; Adhikari N; Zhang W; dos Santos CO; Hall JL; Pomerantz WC ACS Chem Biol; 2015 Oct; 10(10):2246-56. PubMed ID: 26158404 [TBL] [Abstract][Full Text] [Related]
11. Pyronaridine as a Bromodomain-Containing Protein 4- Ibrahim MAA; Abdelhamid MMH; Abdeljawaad KAA; Abdelrahman AHM; Mekhemer GAH; Sidhom PA; Sayed SRM; Paré PW; Hegazy MF; Shoeib T Molecules; 2023 Jul; 28(15):. PubMed ID: 37570684 [TBL] [Abstract][Full Text] [Related]
12. Discovery of novel BRD4-BD2 inhibitors via in silico approaches: QSAR techniques, molecular docking, and molecular dynamics simulations. Tong JB; Xiao XC; Luo D; Xu HY; Xing YC; Gao P; Liu Y Mol Divers; 2024 Apr; 28(2):671-692. PubMed ID: 36773087 [TBL] [Abstract][Full Text] [Related]
13. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1. Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639 [TBL] [Abstract][Full Text] [Related]
14. Auto-FACE: an NMR based binding site mapping program for fast chemical exchange protein-ligand systems. Krishnamoorthy J; Yu VC; Mok YK PLoS One; 2010 Feb; 5(2):e8943. PubMed ID: 20174626 [TBL] [Abstract][Full Text] [Related]
15. A Fragment-Based Ligand Screen Against Part of a Large Protein Machine: The ND1 Domains of the AAA+ ATPase p97/VCP. Chimenti MS; Bulfer SL; Neitz RJ; Renslo AR; Jacobson MP; James TL; Arkin MR; Kelly MJ J Biomol Screen; 2015 Jul; 20(6):788-800. PubMed ID: 25690569 [TBL] [Abstract][Full Text] [Related]
16. Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning. Wang J; Yang W; Zhao L; Wei B; Chen J Molecules; 2024 Apr; 29(8):. PubMed ID: 38675678 [TBL] [Abstract][Full Text] [Related]